THIS paper gives an account of our experience in the use of wedge filters with 4 MV radiation in the treatment of carcinomata of the lower alveolus and of the antrum and accessory sinuses.
With conventional radiation, interest in wedge filter therapy in Manchester was small. The poor depth dose and the loss of wedge angulation created problems of prescription when treating at depth. Some of these have since been solved by Cohen (1959) , but even so, from considerations of the differential absorption in bone, conventional therapy could never be.a serious contender where alternative treatment by radium was available.
Following the introduction of 4 MV radiation, the position immediately changed. Theoretically at least, here was radiation with physical characteristics ideally suited for use with wedge filters. The relative absence of lateral scatter results in a more or less direct relationship between the dose at a point and the intensity of the primary beam through that point. Thus, attenuation of the primary beam, as by a wedge, is reflected accurately by the isodoses. The wedge angulation is thus maintained into depth.
From this same argument the depth dose at any point below an oblique surface is simply calculated, and the necessary correction for such obliquity may be incorporated in the prescription. Correction by use of bolus becomes less important, but may still be necessary in certain sites. In such cases a beam compensator such as that introduced by Ellis et al. (1959) might be used with advantage.
Despite the great advantage of skin sparing with megavoltage radiation, the danger of tumour involvement near the surface must be borne in mind. With 4 MV radiation in the treatment of tumours around the mouth, it is surprising how often bolus is necessary for this reason.
For the criteria of homogeneity and localization, a minimum requirement of three plain fields is necessary, these being arranged symmetrically around the head. With the increased penetration at 4 MV radiation, exactly the same conditions are achieved with only two wedged fields. Even so, for centrally placed tumours, wedge filter therapy can claim no advantage over cross-fire therapy with plain fields. For peripherally placed tumours, however, wedge therapy offers considerable advantage both in simplicity of prescription and in economy of radiation to normal tissues. It is from these theoretical considerations, to which may be added the general advantage of low differential bone absorption, that wedge filter therapy at 4 MV has come to play a substantial part in the treatment of head and neck tumours.
Three wedges of different slopes are in current use-40, 50 and 60 degrees. Considerations of the optimum shape of high dose zone coupled with the degree of surface obliquity dictate the choice of wedge angle.
The use of a variety of wedge angles facilitates the matching of the high dose zone to the tumour shape, thus reducing unnecessary radiation to a minimum. That this is desirable is generally accepted, but so sharp is the fall off at the edge of the treated zone that localization of the tumour must be exact, if it is not to be missed.
Inactive radon seeds are implanted as markers wherever possible and, following the preparation of a plastic beam direction shell, localization is verified radiographically. Prescription is then carried out on a contour taken from the shell.
Lesions of the Lower Alveolus
In the pre-megavoltage era, carcinomata of the lower alveolus were treated in a variety of ways. The small anterior lesion has shown very good results following treatment by a radium mould augmented by a submental radium beam field. Satisfactory results were also achieved on more posterior lesions using the radium beam cluster technique. Radon seed implantation, commonly used in older patients or patients with alveolo-faucial lesions, was rather less successful. Conventional beam direction was the standard radical treatment for lesions of the fauces, but was rarely used for lesions of the alveolus proper.
In the early experimental stage of megavoltage irradiation only very late cases were treated. More recently, 4 MV treatment of lesions of the posterior alveolus has become more routine, but anterior lesions are still, wherever possible, treated by radium mould plus beam.
The 4 MV wedge approach is illustrated in Fig. 1 , using two fields, anterior and lateral. No build-up material is required unless there is extension into the cheek. Toward the further reduction of unnecessary tissue radiation, a block of dental compound, moulded to the patient's bite, is worn during treatment in order to displace the tongue away from the high dose zone. This block serves the additional purpose of preventing any air gaps within the mouth.
Where the lesion extends anteriorly 40-degree wedges are used but where it is more posterior, a more suitable combined isodose plot is obtained with 50-degree wedges (Fig. 2 ). Reaction is thus confined to one side of the mouth, with consequent reduction of discomfort to the patient.
Tumour dosage during the early years ranged from 5,000-5,650 rads in three weeks. Mucosal reactions were in many instances very moderate and we may not have been using the whole of the biological tolerance available. During 1959 this dose has been increased to 6,000 rads in three weeks, without unduly severe reactions.
Lesions of the Antrum and Accessory Sinuses
Pre-megavoltage treatment of these tumours was reported by Gibb (1957) . The megavoltage approach is inevitably dictated by the desire to spare the eyes. High dose conventional radiation of the eyes results in, first, the destruction of the conjunctiva and the cornea and, second, enophthalmos and cataract. It is perhaps worth while to separate the superficial and deep effects in this way, since, with 4 MV radiation, the former seldom occurs, provided that the eye is kept open during treatment. The latter may occur, but this normally does not give rise to pain. Thus the decision to irradiate an eye, when necessary, is made with much less emotional strain.
For treatment considerations, cases may be divided into two categories: A, where involvement is confined to structures below a horizontal plane through the roof of the antrum, and B, where there is extension above this plane.
A.-Treatment planning is simple. A wedge pair from front and side gives adequate coverage (Fig. 3) . The superior edge lies just below the pupil of the eye to ensure clearance of the roof. The posterior border of the lateral field is positioned to cover at least the posterior wall of the antrum, but may be extended if there is evidence of involvement of the pterygoid fossa. The lower limit is dictated by cheek or mouth extension. The customary mouth block is used to keep the lower alveolus and tongue out of the high dose zone. Wax build-up is necessary, if there is extension to the tissues of the cheek.
B.-Where orbit, ethmoid cells or frontal sinuses are also involved, this approach cannot be accepted, because the eye on the sound side would be subtended by the lateral field. An anterior and superior wedge pair surmounts this difficulty (Fig. 4) . On the debit side, however, is a relatively high dose in the frontal lobe, and care must be exercised that the postero-inferior
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Section of FIG. 4. border of the high dose zone does not encroach on the mid-brain. Wax build-up over the ethmoid region is commonly necessary, and in such cases the front field is waxed up completely, thereby simplifying the prescription. A peephole is, however, preserved immediately in front of the pupil, so that the cornea may be spared from the anterior field. In the special case where the tumour is restricted to the apex of the antrum but with lateral involvement of the zygoma and orbit, an alternative plan is possible. Two anterolateral fields, as shown in Fig. 5 , may be arranged to FIG. 5. subtend the involved areas, yet miss the other eye. Such a treatment plan has an obvious weakness in the mid-line posteriorly, and has been used only in these rather restricted circumstances.
One further approach appears to have certain commendable features: The depth dose at 4 MV is relatively independent of area and odd-shaped fields are thus permissible. An L-shaped plain Radiology 241 field from the front can be arranged to subtend frontal sinuses, ethmoid cells, nose and antrum, with no radiation to the eye. This single field has the natural disadvantage of falling dose posteriorly, but if this is boosted by a pait of parallel and opposed wedged fields from the sides, coming in behind the eyes, a relatively homogeneous high dose zone is achieved throughout the tumour volume without radiation to either eye. A cross section below the level of the eyes is shown in Fig. 6 . It has the disadvantage of any single field approach-a rather high exit dose of the order of 60 % tumour dose in brain. Over-enthusiastic and careless shielding of the eyes during treatment may be dangerous.
The early dosage, as with the alveolx, ranged from 5,000 to 5,650 rads in three weeks, a larger proportion being treated at the lower level, in consequence of the larger volume. Again, such dosage was found to be tolerated well with little or no evidence of bone necrosis. Although it is as yet much too soon to assess necrosis risk, we have felt that this level was perhaps on the low side. The current practice is to give 6,000 rads in three weeks, where the treated volume is less than a 7-cm cube. Over this limit, 5,500 or 5,250 rads are given in three weeks, depending on size.
Results
During the experimental phase in 1955, the intent was almost wholly palliative; all cases in that year have therefore been excluded. Radical treatment for patients who would previously have had palliation, plus the selection of early lesions for treatment by well tried radium methods, makes any valid comparison extremely difficult. The fairest comparison that may be made is between radical wedge filter cases in the years 1956 and 1957, and the overall results in mile%
El"% the years 1950 to 1954. These are assessed for survival at two years and also for primary recurrence at two years or at death within that period. The results are given in Tables I and  II . From the figures of primary recurrence 
there may be some suggestion of improvement. The fact that this is not reflected in the survival rate for the alveolar cases is explained by death from metastases or other causes. However, numbers are too small to arrive at any valid conclusions and at this stage there is neither evidence for nor against this mode of treatment. Thus, in conclusion, wedge filter techniques with 4 MV radiation offer a precision and elegance of prescription hitherto not available. In consequence reactions are more localized and treatment more easily tolerated by the patient.
Although as yet no conclusions may be drawn from results, it is hoped that, given optimum dosage, the increased proficiency of technique afforded by wedge filter therapy will express itself in the form of better results. Boland and Paterson (1955) presented to this Society a report on the treatment of carcinoma of the middle ear at the Christie Hospital and Holt Radium Institute, Manchester. At that time the 4 MV linear accelerator became available for routine clinical use and it is now possible to review the treatment of this disease by the linear accelerator and to compare the results with those obtained by methods other than supervoltage.
In order that the present position may be understood fully, it is of advantage to summarize the way in which cancer of the middle ear has been treated in the past at the Christie Hospital. From 1932-1937, the middle ear was exposed at operation and a radium tube of 2 to 5 mg inserted. A dose as high as 5,500 r at 1 cm from the tube was achieved, but the fall off in dose beyond this distance was so rapid that it was impossible to irradiate a sufficiently large volume. This disadvantage was overcome by the use of multifield beam directed X-rays of 250 or 500 kV, and the majority of patients have been treated in this way. One dominant field was balanced by four to six contralateral fields. A tumour dose of 5,000-5,500 r was given in three weeks, or its equivalent dose in five weeks. Better results were obtained by the lower than by the higher of these two dose levels.
Boden (1950) reported a few patients in whom late radiation damage to the brain-stem occurred after treatments of this kind. In 7 patients with damage, the dose in the brain-stem from small fields was between 4,500 and 6,050 r in three weeks. He suggested that 4,500 r in three weeks was the upper limit of safety in the brain-stem.
The middle ear being a cavity in bone made the use of harder radiation desirable, and some patients were later treated by a 10-g radium beam unit. A cluster of three fields from the affected side gave a tumour dose of 4,800-5,500 r in three weeks. Unfortunately, the percentage depth doses from the 10-g beam are low and it was difficult to attain a sufficiently high dose in the deepest part of the irradiated zone.
The physical characteristics of 4 MV X-rays are such as to overcome all the disadvantages of these previous methods. Because of the quality of the beam there is very little differential absorption in bone, while the high percentage depth doses ensure adequate radiation of the whole of the treated volume. In addition, the treatment is made more tolerable by the mild skin reactions. For these reasons, and because the number of patients seen is so small, a trial series by random selection to compare the results of conventional X-rays or radium beam with those of supervoltage was not undertaken when the 4 MV linear accelerator came to be used clinically. Rather it was decided that all cases deemed suitable for radical treatment should be treated by this 4 MV machine. This policy has been consistently followed since then.
Technique.-The technique of treatment on the linear accelerator remains essentially un-
